{"nctId":"NCT00522873","briefTitle":"Endometrial Safety Study","startDateStruct":{"date":"2007-08"},"conditions":["Postmenopause"],"count":662,"armGroups":[{"label":"0.25mg DRSP / 0.5mg E2 (BAY86-4891)","type":"EXPERIMENTAL","interventionNames":["Drug: 0.25mg DRSP / 0.5mg E2 (BAY86-4891)"]},{"label":"0.5mg NETA / 1.0mg E2 (Activella)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: 0.5mg NETA / 1.0mg E2 (Activella)"]}],"interventions":[{"name":"0.25mg DRSP / 0.5mg E2 (BAY86-4891)","otherNames":[]},{"name":"0.5mg NETA / 1.0mg E2 (Activella)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Postmenopausal women between 40 and 65 years of age with hormone therapy indication (symptoms and need for treatment)\n* Non-hysterectomized women.\n\nExclusion Criteria:\n\n* Usual exclusion criteria for hormone therapy apply.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"40 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants in the DRSP/E2 Group With an Assessment of Endometrial Hyperplasia or Worse at End of Study (EoS) (1 Year of Treatment)","description":"The number of women who had a biopsy classified as 'hyperplasia or worse' at any time during the study. According to the protocol this endpoint was defined as primary for the DRSP/E2 group only.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Amenorrhea During Month 1 to 3 of Treatment","description":"The women were to record daily in a diary, indicating 'no bleeding', 'spotting', 'light bleeding', 'normal bleeding' or 'heavy bleeding'. Women were considered to have amenorrhea if they had no bleeding and no spotting day within the given time interval.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"255","spread":null},{"groupId":"OG001","value":"67","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Amenorrhea During Month 10 to 12 of Treatment","description":"The women were to record any bleeding daily in a diary, indicating 'no bleeding', 'spotting', 'light bleeding', 'normal bleeding' or 'heavy bleeding'. Women were considered to have amenorrhea if they had no bleeding and no spotting day within the given time interval.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"280","spread":null},{"groupId":"OG001","value":"89","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":489},"commonTop":["Headache","Breast pain","Influenza","Postmenopausal haemorrhage","Nasopharyngitis"]}}}